Notification of Acceptance for Food with Function Claims Containing Our Ingredient "CI-Dextran mix"

Wellneo Sugar Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Representative Director and President: Koji Yamamoto) announced that the notification for "CI Tablet," a Food with Function Claims containing "CI-Dextran mix," an oral care ingredient manufactured and sold by the company, was accepted on April 22, 2026.

This notification was accepted with the functional ingredient being "cyclic dextran and linear dextran (dietary fiber)" and the functional claim stating that "it has been reported to maintain a good oral environment (suppress plaque formation) for those prone to plaque buildup."

Regarding this notification:

CI-Dextran mix is a raw material ingredient containing "CI (Cyclodextrin)," which is a cyclic oligosaccharide, and linear dextran. CI is an ingredient that has been researched and developed with a focus on enzymes involved in plaque formation.

While there are no current plans for general sales of "CI Tablet," the company will leverage this notification acceptance as a proven track record demonstrating the potential for utilizing CI-Dextran mix in the oral care field for future ingredient proposals.

▶ Our Website "CI-Dextran mix"

▶ Our Functional Ingredient Research Site "CI (Cyclodextrin)"

CI-Dextran mix

Notification Details

Product Name

CI (CI) Tablet

Category

Food with Function Claims

Notification Number

K912

Notifier Name

Wellneo Sugar Co., Ltd.

Food Classification

Processed food (tablets, capsules, etc.)

Functional Ingredients

Cyclic dextran and linear dextran (dietary fiber)

Functional Claim

This product contains cyclic dextran and linear dextran (dietary fiber). Cyclic dextran and linear dextran (dietary fiber) have been reported to maintain a good oral environment (suppress plaque formation) for those prone to plaque buildup.

Contact for this matter

Wellneo Sugar Co., Ltd. Neo Functional Ingredients Department

TEL: 03-3668-1106

MAIL: neo_sales@wellneo-sugar.co.jp